Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|July 18, 2006
Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)Luis E Raez, Edgardo S Santos, Gilberto Lopes, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 27, 2023
Pancreatic adverse events in patients treated with immune checkpoint inhibitorsCaroline Hana, Tauseef Rehman, Kyeeun Park, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic diseaseOscar Arrieta, Alejandro Avilés Salas, Andrés F Cardona, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatmentsLuis E Raez, Andrés F Cardona, Edgardo S Santos, et al.
Clinical Lung Cancer|July 19, 2016
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin AmericaLuis E Raez, Edgardo S Santos, Christian Rolfo, et al.
BMC Cancer|October 18, 2023
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencingMisako Nagasaka, Shannon S Zhang, Yasmine Baca, et al.
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Oral Oncology|April 20, 2012
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neckCesar A Perez, Hunho Song, Luis E Raez, et al.
ESMO Open|April 24, 2018
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?Joseph A Pinto, Carlos S Vallejos, Luis E Raez, et al.
Scientific Reports|May 10, 2017
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignanciesJoseph A Pinto, Christian Rolfo, Luis E Raez, et al.
Pageof 16